TABLE 5.
PANSS-T | PANSS-P | PANSS-N | PANSS-G | |
---|---|---|---|---|
Trp | −0.16 | 0.0021 | 0.0019 | −0.35 |
(p = 0.40) | (p = 0.99) | (p = 0.99) | (p = 0.06) | |
Kyn | −0.17 | −0.054 | −0.039 | −0.28 |
(p = 0.38) | (p = 0.78) | (p = 0.84) | (p = 0.14) | |
3-HK | −0.08 | 0.12 | −0.044 | −0.13 |
(p = 0.68) | (p = 0.53) | (p = 0.82) | (p = 0.50) | |
QA | −0.3 | −0.21 | −0.15 | −0.44 |
(p = 0.16) | (p = 0.35) | (p = 0.45) | (p = 0.043) | |
5-HT | 0.19 | 0.099 | 0.1 | 0.18 |
(p = 0.33) | (p = 0.60) | (p = 0.58) | (p = 0.33) | |
Kyn/Trp | −0.025 | −0.0078 | −0.028 | −0.0045 |
(p = 0.89) | (p = 0.97) | (p = 0.88) | (p = 0.98) | |
5HT/Kyn | 0.22 | 0.13 | 0.067 | 0.27 |
(p = 0.25) | (p = 0.51) | (p = 0.73) | (p = 0.14) | |
3-HK/Kyn | 0.078 | 0.27 | 0.014 | 0.048 |
(p = 0.68) | (p = 0.15) | (p = 0.94) | (p = 0.80) | |
QA/Kyn | −0.5 | −0.38 | −0.24 | −0.64 |
(p = 0.017) | (p = 0.076) | (p = 0.28) | (p = 0.0014) | |
IL-6 | −0.33 | −0.2 | −0.28 | −0.29 |
(p = 0.080) | (p = 0.30) | (p = 0.14) | (p = 0.13) | |
TNF-α | −0.24 | −0.2 | −0.13 | −0.21 |
(p = 0.21) | (p = 0.30) | (p = 0.49) | (p = 0.26) | |
hsCRP | −0.26 | −0.28 | −0.04 | −0.29 |
(p = 0.18) | (p = 0.15) | (p = 0.84) | (p = 0.13) | |
BDNF | −0.34 | −0.21 | −0.38 | −0.23 |
(p = 0.064) | (p = 0.26) | (p = 0.038) | (p = 0.22) |
PANSS, Positive and Negative Syndrome Scale; PANSS-T, PANSS Total; PANSS-P, PANSS Positive; PANSS-N, PANSS Negative; PANSS-G, PANSS General; Trp, tryptophan; Kyn, kynurenine; 3-HK, 3-hydroxykynurenine; QA, quinolinic acid; 5-HT, 5-hydroxytryptamine; KynA, kynurenic acid; hsCRP, high-sensitivity C-reactive protein; BDNF, brain-derived neurotrophic factor; IL, interleukin; TNF-α, tumor necrosis factor alpha. Statistically significant differences at P <0.05 is in bold. Positive correlations are shown in red, negative correlations are shown in blue, and the strength of the correlation is expressed in terms of concentration.